Outcomes of A Virtual Practice-Tailored Medicare Annual Wellness Visit Intervention.
Early Medical Intervention
Geriatrics
Medicare
Preventive Health Services
Virtual Systems
Journal
Journal of the American Board of Family Medicine : JABFM
ISSN: 1558-7118
Titre abrégé: J Am Board Fam Med
Pays: United States
ID NLM: 101256526
Informations de publication
Date de publication:
08 May 2023
08 May 2023
Historique:
received:
28
09
2022
revised:
03
01
2023
accepted:
09
01
2023
medline:
12
6
2023
pubmed:
8
4
2023
entrez:
7
4
2023
Statut:
ppublish
Résumé
Interventions are needed to promote utilization of the Medicare Annual Wellness Visit (AWV), an underused opportunity to perform screenings and plan individualized preventive health services. Using remote practice redesign and electronic health record (EHR) support, we implemented the Practice-Tailored AWV intervention in 2021 (during the COVID-19 pandemic) in 3 small community-based practices. The intervention combines EHR-based tools with practice redesign approaches and resources. Outcomes included completion of AWV and fulfillment of recommended preventive services. At baseline the 3 practices had 1,513 Medicare patients with at least 1 visit in the past 12 months. AWV utilization went from 7% at baseline to 54% 8 months postintervention implementation; advance care planning increased 10.7% (from 7.9% to 18.6%); depression screening increased 16.3% (from 51.7% to 68.0%); and alcohol misuse screening increased 17.3% (from 42.6% to 59.9%). Every individual preventive health service was received more often by patients with an AWV than those without. At the patient level, fulfillment of all eligible preventive services (of a maximum of 12 evaluated) went from 47.5% to 53.8% ( Virtual implementation of an intervention that combined EHR-based tools with practice redesign approaches increased AWV and preventive services utilization in Medicare patients. Given the success of this intervention during the COVID-19 pandemic (when practices had many competing demands), greater consideration should be given to delivering future interventions virtually.
Identifiants
pubmed: 37028913
pii: jabfm.2022.220342R1
doi: 10.3122/jabfm.2022.220342R1
pmc: PMC10352446
mid: NIHMS1909150
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
501-509Subventions
Organisme : NIA NIH HHS
ID : R33 AG068946
Pays : United States
Organisme : NIA NIH HHS
ID : R61 AG068946
Pays : United States
Informations de copyright
© Copyright by the American Board of Family Medicine.
Déclaration de conflit d'intérêts
Conflict of interest: Dr. Tarn has been funded by the BMS/Pfizer Alliance ARISTA-USA to conduct unrelated research studies.
Références
J Am Pharm Assoc (2003). 2017 May - Jun;57(3S):S247-S251
pubmed: 28400254
J Nurs Adm. 2014 May;44(5):270-5
pubmed: 24759199
Prev Med. 2019 Dec;129:105850
pubmed: 31629799
Am J Health Syst Pharm. 2017 Feb 15;74(4):218-223
pubmed: 28179248
Ann Intern Med. 2022 Aug;175(8):1179-1180
pubmed: 35759763
Ann Intern Med. 2022 Aug;175(8):1100-1108
pubmed: 35759760
Med Care. 2018 Sep;56(9):761-766
pubmed: 30015726
J Am Pharm Assoc (2003). 2014 Jul-Aug;54(4):427-34
pubmed: 25063263
J Am Pharm Assoc (2003). 2015 Jul-Aug;55(4):449-54
pubmed: 26161489
Prev Med Rep. 2017 Dec 27;10:210-211
pubmed: 29868370
Vaccine. 2017 Dec 15;35(50):6938-6940
pubmed: 29089193
N C Med J. 2017 Sep-Oct;78(5):287-295
pubmed: 28963260
Fam Med. 2015 Jul-Aug;47(7):558-61
pubmed: 26562646
JAMA. 2017 Jun 6;317(21):2233-2235
pubmed: 28423397
Am J Health Syst Pharm. 2014 Jan 1;71(1):44-9
pubmed: 24352181